85 related articles for article (PubMed ID: 22344624)
1. Acute treatment with candesartan cilexetil, an angiotensin II type 1 receptor blocker, improves insulin sensitivity in high-fructose-diet-fed rats.
Li P; Koike T; Jiang HY; Wang ZH; Kawata Y; Oshida Y
Horm Metab Res; 2012 Apr; 44(4):286-90. PubMed ID: 22344624
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin II AT1 receptor inhibition and exercise training on insulin action in rats on high-fat diet.
Wang Z; Koike T; Li P; Jiang H; Natsume Y; Mu L; Chen T; Oshida Y
Life Sci; 2012 Feb; 90(9-10):322-7. PubMed ID: 22210187
[TBL] [Abstract][Full Text] [Related]
3. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet.
Qin B; Nagasaki M; Ren M; Bajotto G; Oshida Y; Sato Y
Horm Metab Res; 2004 Feb; 36(2):119-25. PubMed ID: 15002064
[TBL] [Abstract][Full Text] [Related]
4. [Effects of angiotensin II type 1 receptor blocker on islet of diabetic db/db mice].
Shao JQ; Iwashita N; Du H; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):306-10. PubMed ID: 17637271
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice.
Shao J; Iwashita N; Ikeda F; Ogihara T; Uchida T; Shimizu T; Uchino H; Hirose T; Kawamori R; Watada H
Biochem Biophys Res Commun; 2006 Jun; 344(4):1224-33. PubMed ID: 16650382
[TBL] [Abstract][Full Text] [Related]
6. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
7. Repeated application of low-frequency electroacupuncture improves high-fructose diet-induced insulin resistance in rats.
Tominaga A; Ishizaki N; Naruse Y; Kitakoji H; Yamamura Y
Acupunct Med; 2011 Dec; 29(4):276-83. PubMed ID: 21697213
[TBL] [Abstract][Full Text] [Related]
8. Infusion of beta-endorphin improves insulin resistance in fructose-fed rats.
Su CF; Chang YY; Pai HH; Liu IM; Lo CY; Cheng JT
Horm Metab Res; 2004 Aug; 36(8):571-7. PubMed ID: 15326568
[TBL] [Abstract][Full Text] [Related]
9. TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation.
Iwai M; Chen R; Imura Y; Horiuchi M
Am J Hypertens; 2007 May; 20(5):579-86. PubMed ID: 17485025
[TBL] [Abstract][Full Text] [Related]
10. [Candesartan improves insulin resistance induced by high-fat diet in rats].
Yan WH; Dou JT; Pan CY; Chen K; Wang XM; Ma FL; Yang GQ; Wang XL; Mu YM; Lu JM
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2695-9. PubMed ID: 19080690
[TBL] [Abstract][Full Text] [Related]
11. Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats.
Liu IM; Tzeng TF; Liou SS; Lan TW
Life Sci; 2007 Nov; 81(21-22):1479-88. PubMed ID: 17976658
[TBL] [Abstract][Full Text] [Related]
12. A high-fructose diet impairs Akt and PKCzeta phosphorylation and GLUT4 translocation in rat skeletal muscle.
Li P; Koike T; Qin B; Kubota M; Kawata Y; Jia YJ; Oshida Y
Horm Metab Res; 2008 Aug; 40(8):528-32. PubMed ID: 18500676
[TBL] [Abstract][Full Text] [Related]
13. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
[TBL] [Abstract][Full Text] [Related]
14. Candesartan: widening indications for this angiotensin II receptor blocker?
Mendis B; Page SR
Expert Opin Pharmacother; 2009 Aug; 10(12):1995-2007. PubMed ID: 19563275
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
[TBL] [Abstract][Full Text] [Related]
16. Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy.
Haneda M; Kikkawa R; Sakai H; Kawamori R;
Diabetes Res Clin Pract; 2004 Oct; 66(1):87-95. PubMed ID: 15364166
[TBL] [Abstract][Full Text] [Related]
17. Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats.
Shimamoto K; Matsuda K; Takizawa H; Higashiura K; Ura N; Iimura O
Blood Press Suppl; 1994; 5():113-6. PubMed ID: 7889192
[TBL] [Abstract][Full Text] [Related]
18. Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats.
Hashikawa-Hobara N; Hashikawa N; Inoue Y; Sanda H; Zamami Y; Takatori S; Kawasaki H
Diabetes; 2012 Apr; 61(4):925-32. PubMed ID: 22357959
[TBL] [Abstract][Full Text] [Related]
19. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
20. Candesartan cilexetil effectively reduces blood pressure in hypertensive children.
Franks AM; O'Brien CE; Stowe CD; Wells TG; Gardner SF
Ann Pharmacother; 2008 Oct; 42(10):1388-95. PubMed ID: 18664605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
